Journal Information
Vol. 45. Issue S3.
XIV Eurasian Hematology Oncology Congress
Pages S46-S47 (October 2023)
Share
Share
Download PDF
More article options
Vol. 45. Issue S3.
XIV Eurasian Hematology Oncology Congress
Pages S46-S47 (October 2023)
Pediatric Oncology Abstract CategoriesRare Tumours and HistiocytosisPP 34
Full text access
TWO RARE CASES OF SUBGLOTTIC HEMANGIOMA TREATED WITH PROPRANOLOL
Visits
327
Melda Berber Hamamcı1, Şule Yeşil1, Firdevs Aydın1, Gülcan Erbaş2, Deniz Tuğcu2, Şifa Şahin2, Zuhal Bayramoğlu3, Yasin Ateş2, Serap Karaman2, Hikmet Gülşah Yıldız2, Hakan Kocaman4, Elif Dede5, Ayper Somer5, Ayşegül Ünüvar2, Zeynep Karakaş2
1 Ankara Etlık Cıty Hospital
2 Istanbul Faculty Of Medıcıne, Pedıatrıc Oncology And Hematology Department
3 Istanbul Faculty Of Medıcıne Radıology Department
4 Istanbul Faculty Of Medıcıne Pedıatrıc Surgery Department
5 Istanbul Faculty Of Medıcıne, Chıld Infectıon Department
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (2)
Special issue
This article is part of special issue:
Vol. 45. Issue S3

XIV Eurasian Hematology Oncology Congress

More info
Case report

The 22-month-old male and 15-day-old female patients presented with persistent stridor since birth. Tracheoscopy of the first patient revealed a 90% obstructing hemangioma in the subglottic area, while the second patient's CT scan showed a hemangioma at the subglottic level. Both patients were initiated on propranolol therapy. These cases highlight the significance of subglottic hemangioma as a treatable cause of stridor in infants and emphasize the importance of propranolol treatment.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools